Failure of pre-exposure prophylaxis with on-demand tenofovir disoproxil fumarate/emtricitabine resulting in emergence of antiretroviral resistance.

J Microbiol Immunol Infect

Department of Internal Medicine, National Taiwan University Hospital and National Taiwan University College of Medicine, Taipei, Taiwan; Department of Tropical Medicine and Parasitology, National Taiwan University Hospital, Taipei, Taiwan.

Published: August 2021

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jmii.2021.01.011DOI Listing

Publication Analysis

Top Keywords

failure pre-exposure
4
pre-exposure prophylaxis
4
prophylaxis on-demand
4
on-demand tenofovir
4
tenofovir disoproxil
4
disoproxil fumarate/emtricitabine
4
fumarate/emtricitabine emergence
4
emergence antiretroviral
4
antiretroviral resistance
4
failure
1

Similar Publications

Background: Key populations (KP) are highly vulnerable to HIV acquisition and account for 70% of new infections worldwide. To optimize HIV prevention among KP, the World Health Organization recommends the combination of emtricitabine plus tenofovir disoproxil fumarate for pre-exposure prophylaxis (PrEP). However, PrEP failure could be attributed to drug resistance mutations (DRMs) but this is unexplored in sub-Saharan Africa (SSA).

View Article and Find Full Text PDF

Real-world experience of tixagevimab/cilgavimab prophylaxis in Japanese patients with immunodeficiency.

J Infect Chemother

December 2024

Department of Child Health and Development, Graduate School of Medical and Dental Sciences, Institute of Science Tokyo, 1-5-45 Yushima, Bunkyo-ku, 113-8519, Tokyo, Japan. Electronic address:

Background: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) causes severe illness and mortality in patients with immunodeficiency. Although vaccination has been recommended, the induction of protective antibodies by immunization, and thus the disease-preventive effect, has proven insufficient in immunodeficient patients, especially in those with predominantly antibody deficiency. A monoclonal antibody combination of tixagevimab and cilgavimab (TIX/CIL) was developed as a pre-exposure prophylaxis (PrEP).

View Article and Find Full Text PDF

Introduction: PrEP, a highly effective HIV prevention measure, provides autonomy to individuals in managing their HIV acquisition vulnerability. Despite its availability in tenofovir-based oral pills and injectable cabotegravir formulations, PrEP uptake among Black cisgender women in the U.S.

View Article and Find Full Text PDF

Introduction: COVID-19 is a continuing challenge for immunocompromised patients with hematological malignancies. Such patients are at increased risk for complications, including hospitalization, respiratory failure, delayed anti-cancer therapies, and even death. In addition to non-pharmacologic interventions, the main strategies for prevention in such patients are vaccination and pre-exposure prophylaxis.

View Article and Find Full Text PDF

Impaired pheromone detection and abnormal sexual behavior in female mice deficient for ancV1R.

Curr Biol

November 2024

Department of Life Science and Technology, School of Life Science and Technology, Institute of Science Tokyo, Yokohama 226-8501, Japan; Center for Integrative Biosciences, Institute of Science Tokyo, Yokohama 226-8501, Japan. Electronic address:

Article Synopsis
  • - The ancient vomeronasal receptor type-1 (ancV1R) is important for pheromone sensing and is found in many vertebrates, but its specific function is not yet fully understood.
  • - Researchers studied female mice lacking ancV1R and found that these mice showed rejection of male sexual behavior and did not respond to male urine as potential mating cues.
  • - The absence of ancV1R disrupted the normal physiological responses in the vomeronasal organ, leading to abnormal sexual behaviors and increased stress responses when in contact with males, suggesting its key role in mate recognition.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!